Aortic Valve

Question 0

Name: Root Enlargement in the left-non commissure and carried onto the anterior leaflet of mitral valve w Dacron patch enlargement.

Answer 0

Manougian: pistop MR in up to 14%.

Question 1

Name: Root Enlargement in the left-non commissure w Dacron patch enlargement.

Answer 1

Nicks- can be used w mechanical AVR or as part of a homografts root replacement.

Question 2

Name: Anterior root enlargement into RVOT

Answer 2

Konno- oversize mechanical prosthesis can cause protection into RVOT as well as distortion of the coronary arteries the results and ischemia. Gluteraldehyde treated pericardium used in younger patients; Dacron used for older children

Question 3

AS time to death from CHF

Answer 3

2 years

Question 4

AS time to death from Syncope

Answer 4

3 years

Question 5

AS time to death from angina.

Answer 5

5 years.

Question 6

Criteria for severe AS

Answer 6

Mean dP >40mmHg or

VMax >4 m/s

Question 7

Overall mortality for isolated AVR

Answer 7

2-5%

Question 8

Bioprosthetic thromboembolic risk

Answer 8

1% per patient year

Question 9

Mechanical thromboembolic risk

Answer 9

2% per patient year

Question 10

Bioprosthetic major bleeding risk

Answer 10

0.3% per patient year

Question 11

Mechanical severe bleeding risk

Answer 11

2-3% per patient-year

Question 12

Anticipated durability of bio prosthetic valves

Answer 12

15 years

Question 13

Bio prosthetic freedom from structural valve deterioration at 12 years.

Answer 13

90%